Under pathological conditions, the overexpression of TGF-β causes EndMT, epithelial-mesenchymal transition (EMT), ECM deposition, and cancer-associated fibroblast (CAF) formation, which can lead to fibrotic disease, and cancer [23, 24]. This evidence concerns the gene TGFB1 and cancer.